Showing results (301-310 of 321) with videos related to
Sort By:
Pageof 33
Journal of the American Society of Nephrology : JASN|March 29, 2014
Role of podocyte B7-1 in diabetic nephropathyPaolo Fiorina, Andrea Vergani, Roberto Bassi, et al.Journal of the American Society of Nephrology : JASN|September 23, 2020
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKITariq U Azam, Husam R Shadid, Pennelope Blakely, et al.Diabetes Care|January 19, 2022
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Elizabeth Anderson, Husam Shadid, et al.Critical Care Medicine|February 23, 2024
Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International StudyAthanasios Chalkias, Yiyuan Huang, Anis Ismail, et al.The Journal of Clinical Investigation|January 29, 2020
Phase I trial of donor-derived modified immune cell infusion in kidney transplantationChristian Morath, Anita Schmitt, Christian Kleist, et al.Genome Biology|May 10, 2022
Refining colorectal cancer classification and clinical stratification through a single-cell atlasAteeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, et al.Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.Journal of the American Heart Association|August 4, 2022
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.Nature Immunology|December 11, 2019
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activationStephen Zewinger, Jochen Reiser, Vera Jankowski, et al.Pageof 33